Adjuvant Therapy With Vitamin D Showing Promising Results In COVID-19 Patients

ISLAMABAD, Aug 1 (UrduPoint / Pakistan Point News - 1st Aug, 2021 ) :Adjuvant therapy with Vitamin D has shown promising results in the COVID-19 patients according to the landmark victory trial conducted on the role of Vitamin D recently here in a conference.

The second international PSIM conference was held at the a local hotel under the theme titled "Evidence based Medicine Apnao".� Speaking on the occasion President Pakistan Society of Internal Medicine (PSIM) and Vice Chancellor University of Health Sciences,�Lahore, Prof. Dr. Javed Akram said that adjuvant therapy with Scotmann's SunnyD STAT softgel (Vitamin D3 200000 IU) has showed promising results in COVID-19 patients whose initial inflammatory Cytokine signatures were predicting potential development of Cytokine storm.

"This is also the first time in Pakistan that Real-Time genetic expressions were analyzed through RT-PCR , which can help predict and consequently prevent the development of Cytokine storm, the main killer in COVID-19 patients", Dr.

Akram said.

The results were announced under the chairmanship of Senior Vice President PSIM and Secretary General� PSIM, Prof. Aftab Mohsin� and Dr. Somia Iqtadar respectively.

The results would be published under the umbrella of UPAS Institute of Vitamin D Research , a combined collaboration between University of Health Sciences,� Pakistan Society of Internal Medicine Foundation,� Akram Medical Complex and Scotmann Pharmaceuticals to promote Vitamin D related research,� awareness and academic programmes.

Chairperson Akram Medical Complex, Dr. Shehla Akram and Senior Vice President PSIM, Professor, Dr. Sajid Ubaidullah were also present on the occasion.